A-SEEDS
Matsumoto, JP · 3 known investors
A-SEEDS is a Shinshu University spin-out developing non-viral gene-modified immune cell therapies, including non-viral CAR-T cell products, to treat pediatric and young-adult cancers, including solid tumors, that lack effective treatments. The company focuses on advancing basic research through non-clinical development into clinical application of these cancer cell therapies.
BiotechDeep TechHealthtechMedical Devices
Founders & leadership
YN
Yozo NakazawaFounder & Director; Professor, Department of Pediatrics, Shinshu University
SY
Shigeki YagyuRepresentative Director (CEO)
TA
Takuji AchihaChief Development Officer
KT
Kiyohito TaniChief Operating Officer